13 December 2019 For women at high risk for breast cancer, tamoxifen and raloxifene have both been shown to be effective in reducing risk by approximately 30-40%. A recent small study found that low dose (5mg) of tamoxifen is also effective for risk reduction. In post-menopausal women with a history of breast cancer, it is […]

12 December 2019 A study presented at the San Antonio Breast Cancer Symposium last week provides more evidence to support the use of accelerated partial breast irradiation (APBI) after lumpectomy in selected patients with breast cancer. Radiation after lumpectomy typically treats the entire breast (whole breast irradiation, WBI) and is usually administered daily for 3-6 […]

28 November 2019 A study recently published in the New England Journal of Medicine* suggests that the use of breast MRI in addition to mammograms in women with extremely dense breast can improve the rate of “interval cancer” detection. Interval cancers are those that occur after an apparently normal mammogram, but prior to the next […]

21 November 2019 Following lumpectomy, radiation therapy to the whole breast is a standard part of breast conserving therapy (BCT). The use of radiation therapy after lumpectomy has been shown to reduce local (in the breast) recurrence rates. Radiation therapy can be administered in several ways, but most commonly, the whole breast is treated (whole […]

20 November 2019 One of the challenges in treating male breast cancer is that there are few studies specifically focusing on men. Breast cancer is much less common in men than in women (approximately 2600 versus 260,000 cases per year in the US). However, men tend to be treated using the same protocols that are […]

13 November 2019 The UCLA Center for Health Policy Research (UCLA CHPR) is developing a report on metastatic breast cancer, with the goal to drive actionable change in policy and practice. On Monday November 18th, the community will be asked to provide their thoughts for the UCLA CHPR team as part of their research study. […]

21 October 2019 Especially during October, when everything seems to be painted pink, it’s easy to overlook the fact that breast cancer is a disease of women and men. Male breast cancer accounts for 0.6 – 1.0% of all breast cancer cases. In the US, approximately 2600 men will be diagnosed with breast cancer each year. The […]